Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Aligos Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +9 vs. Q4 2023
- Shares held
- 46.2M
- +863.8K (+1.9%) vs. Q4 2023
- Total value
- $45.3M
- +$15.2M (+50.4%) vs. Q4 2023
- New holders
- 11
- 13 more added
- Sold out
- 2
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 6,893,410 | $6.76M | 0.18% | +59,535+0.9% | Added |
| EcoR1 Capital, LLC | 6,389,468 | $6.26M | 0.16% | 00.0% | Unchanged |
| Deep Track Capital, LP | 6,102,770 | $5.98M | 0.17% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,547,030 | $3.48M | 0.27% | 00.0% | Unchanged |
| Altitude Crest Partners Inc. | 2,844,681 | $2.79M | 1.19% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,464,505 | $2.42M | 0.00% | +2,464,505 | New |
| Versant Venture Management, LLC | 2,320,381 | $2.27M | 2.20% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,076,400 | $2.03M | 0.03% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,906,191 | $1.87M | 0.04% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,650,000 | $1.62M | 0.17% | −539,847−24.7% | Reduced |
| Opaleye Management Inc. | 1,630,000 | $1.60M | 0.35% | +333,000+25.7% | Added |
| Newtyn Management, LLC | 1,200,000 | $1.18M | 0.23% | −55,000−4.4% | Reduced |
| Bank of America Corp | 1,147,727 | $1.12M | 0.00% | −350.0% | Reduced |
| Vanguard Group Inc | 1,013,067 | $992.8K | 0.00% | +1,416+0.1% | Added |
| Renaissance Technologies LLC | 808,260 | $792.0K | 0.00% | +318,300+65.0% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $728.4K | 0.47% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 657,995 | $644.0K | 0.00% | +98,628+17.6% | Added |
| Silverarc Capital Management, LLC | 655,515 | $642.4K | 0.18% | −12,997−1.9% | Reduced |
| UBS Oconnor LLC | 500,000 | $490.0K | 0.01% | +500,000 | New |
| Geode Capital Management, LLC | 373,056 | $365.7K | 0.00% | +52,012+16.2% | Added |
| BlackRock Inc. | 303,755 | $297.7K | 0.00% | +7,616+2.6% | Added |
| Citadel Advisors LLC | 285,679 | $280.0K | 0.00% | +285,679 | New |
| Millennium Management LLC | 110,661 | $108.4K | 0.00% | +81,956+285.5% | Added |
| State Street Corp | 97,423 | $95.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 92,015 | $90.2K | 0.00% | +38,047+70.5% | Added |
| Bridgeway Capital Management, LLC | 92,000 | $90.2K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 44,871 | $44.0K | 0.01% | +19,128+74.3% | Added |
| Atom Investors LP | 34,173 | $33.5K | 0.00% | +34,173 | New |
| Charles Schwab Investment Management Inc | 31,383 | $30.8K | 0.00% | 00.0% | Unchanged |
| Choate Investment Advisors | 24,000 | $23.5K | 0.00% | 00.0% | Unchanged |
| Procyon Private Wealth Partners, LLC | 20,000 | $19.6K | 0.00% | +20,000 | New |
| HarbourVest Partners LLC | 18,783 | $18.4K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 18,624 | $18.3K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 16,891 | $17.0K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 15,525 | $15.2K | 0.00% | +5,475+54.5% | Added |
| ZWJ Investment Counsel Inc | 14,500 | $14.2K | 0.00% | +14,500 | New |
| Zullo Investment Group, Inc. | 13,000 | $12.7K | 0.01% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 12,500 | $12.3K | 0.00% | +12,500 | New |
| UBS Group AG | 10,825 | $10.6K | 0.00% | +10,825 | New |
| Financial Advocates Investment Management | 10,000 | $9.80K | 0.00% | +10,000 | New |
| Total Clarity Wealth Management, Inc. | 10,000 | $9.80K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 8,022 | $7.86K | 0.00% | −10,706−57.2% | Reduced |
| Morgan Stanley | 3,300 | $3.23K | 0.00% | +1,300+65.0% | Added |
| Simplex Trading, LLC | 1,104 | $1.00K | 0.00% | +1,104 | New |
| JPMorgan Chase & Co | 677 | $663 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 298 | $292 | 0.00% | +5+1.7% | Added |
| ZRC Wealth Management, LLC | 100 | $98 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 124 | $0 | 0.00% | −317−71.9% | Reduced |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −2,882,216−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,739−100.0% | Sold out |